Lab Automation Global Market Report 2024

The lab automation market size has grown strongly in recent years. It will grow from $6.67 billion in 2023 to $7.33 billion in 2024 at a compound annual growth rate (CAGR) of 9.9%. The expansion observed during the historical period can be attributed to the miniaturization of assays and instruments, advancements in robotics and automation technologies, increased demand for high-throughput screening in drug discovery, growing emphasis on precision and reproducibility in research, and the necessity for faster and more accurate diagnostic testing.

The lab automation market size is expected to see rapid growth in the next few years. It will grow to $10.8 billion in 2028 at a compound annual growth rate (CAGR) of 10.2%. The anticipated growth in the forecast period can be attributed to regulatory compliance requirements, the increasing demand for remote access and monitoring capabilities, challenges related to labor shortages and skills gaps, the rising demand for high-throughput screening, and the pressure to reduce costs. Significant trends expected in the forecast period include the integration of artificial intelligence (AI) and machine learning algorithms, the expansion of robotic automation, the adoption of modular and scalable automation solutions, increased utilization of high-throughput screening technologies, and the incorporation of advanced imaging and microscopy techniques.

The increasing demand for personalized medicine is set to drive the growth of the lab automation market in the coming years. Personalized medicine, also referred to as precision medicine, involves tailoring healthcare decisions, interventions, and treatments to individual patients. This demand is rising due to advancements in genomics and molecular diagnostics, greater awareness and education, the growing burden of chronic diseases, and its cost-effectiveness. Lab automation enhances the efficiency, precision, and scalability of laboratory procedures, enabling healthcare professionals and researchers to develop personalized medicine approaches that enhance patient outcomes and optimize treatment effectiveness. For example, as of October 2022, the Personalized Medicine Coalition (PMC) reported that over 75,000 genetic testing products and 300 personalized medicines would be available on the market for various conditions, including multiple types of cancer, genetic rare diseases, and chronic and infectious diseases. Consequently, the increasing demand for personalized medicine is stimulating growth in the lab automation market.

Leading companies in the lab automation market are innovating by creating solutions such as lab automation systems tailored for microbiology laboratories, aiming to optimize laboratory space and streamline workflows. These systems are sophisticated technological solutions designed to enhance the processing, analysis, and management of microbiological samples and data. For instance, in January 2023, Becton, Dickinson, and Company introduced the third-generation BD Kiestra Total Lab Automation System for microbiology laboratories. This modular system is adaptable to meet the specific requirements of laboratories, improving operational efficiency, maximizing budgetary resources, and enhancing laboratory outcomes. Featuring fully automated robotic capabilities, the system streamlines microbiology laboratory processes such as sample processing, digital imaging, incubation, and result analysis. Moreover, its automated microbiology procedures, modular design, scalability, integration with the BD Synapys microbiology informatics solution, and high throughput capabilities are poised to revolutionize clinical bacteriological testing, improve laboratory outcomes, and address the evolving needs of modern microbiology laboratories.

In March 2024, Bruker Corporation acquired Chemspeed Technologies AG to bolster productivity in research and development (R&D) and quality control (QC) departments. This acquisition enables Bruker to offer modular automation solutions that enhance R&D productivity across various industries, including pharmaceuticals, biotech, chemicals, materials, cosmetics, and food. Chemspeed Technologies AG specializes in providing high-throughput and high-output research and development and quality control workflow solutions, making it a valuable addition to Bruker's portfolio.

Major companies operating in the lab automation market are Thermo Fisher Scientific, Becton Dickinson And Company (BD), Agilent Technologies Inc., PerkinElmer LLC, Beckman Coulter Inc., Biomek Inc., Bio-Rad Laboratories, QIAGEN N.V., Tecan Group, Brooks Life Sciences, Hamilton Company, Promega Corporation, Opentrons Labworks Inc, Analytik Jena AG, Gilson Inc., Eppendorf Corporate, Hudson Robotics, Cartesian Therapeutics, Labcyte Inc. (now part of Beckman Coulter Life Sciences), Zymo Research Corp., Perceptive Instruments Ltd., Synthace Ltd., Festo Corp., Roche Diagnostics, Peak Analysis & Automation (PAA)

North America was the largest region in the lab automation market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the lab automation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the lab automation market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Lab automation involves leveraging technology and machinery to streamline and enhance laboratory processes, minimizing manual intervention and boosting efficiency. It encompasses a multi-disciplinary approach aimed at researching, developing, optimizing, and leveraging technologies within the laboratory to enable new and improved processes.

The primary stages in lab automation include the pre-analytical stage, analytical stage, post-analytical stage, and total lab automation. The pre-analytical stage in laboratory medicine refers to the testing phase preceding the actual analysis of a specimen. It encompasses various processes such as discrete processing and continuous flow and finds applications in diagnostics, genomic solutions, microbiology, drug discovery, proteomic solutions, among others. It serves diverse end-users including pharmaceutical and biotechnology companies, research and diagnostic laboratories, among others.

The lab automation market research report is one of a series of new reports that provides lab automation market statistics, including lab automation industry global market size, regional shares, competitors with a lab automation market share, detailed lab automation market segments, market trends and opportunities, and any further data you may need to thrive in the lab automation industry. This lab automation market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The lab automation market includes revenues earned by entities by providing services such as workflow analysis and optimization, system integration, custom software development, instrument maintenance and support, and training. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.